• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名非洲儿童的嗜酸性粒细胞增多症和严重骨病:一个意外的诊断。

Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis.

作者信息

Bota Sofia, Alves Pedro, Constantino Claudia, Maia Raquel

机构信息

Women, Child and Adolescents Department, Hospital Dona Estefania, Lisboa, Portugal.

Radiology Department, Hospital Dona Estefania, Lisboa, Portugal.

出版信息

BMJ Case Rep. 2019 Apr 29;12(4):e227653. doi: 10.1136/bcr-2018-227653.

DOI:10.1136/bcr-2018-227653
PMID:31036733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6506024/
Abstract

Hypereosinophilic syndromes are rare in children. Sporadic, mild-severity FIP1L1-platelet-derived growth factor receptor α (PDGFRα) rearrangement cases have been reported, mainly in boys. We present the case of a 5-year-old girl referred from her African country of birth, due to severe constitutional symptoms, multifocal bone pain, headache, gastrointestinal complaints, cardiomyopathy and unexplained hypereosinophilia. She presented multiple end-organ diseases and striking bone involvement. Although she had a positive serology for , extensive evaluation detected a FIP1L1-PDGFRA fusion gene. Systemic corticosteroids and low-dose imatinib were started and the child became asymptomatic. After 9 months of treatment, FIP1L1-PDGFRA was no longer detected.

摘要

嗜酸性粒细胞增多综合征在儿童中较为罕见。曾有散发的轻度至重度FIP1L1-血小板衍生生长因子受体α(PDGFRα)重排病例的报道,主要见于男孩。我们报告了一名5岁女孩的病例,她从出生的非洲国家转诊而来,有严重的全身症状、多灶性骨痛、头痛、胃肠道不适、心肌病和不明原因的嗜酸性粒细胞增多。她出现了多种终末器官疾病和明显的骨骼受累。尽管她的血清学检查呈阳性,但广泛评估发现了FIP1L1-PDGFRA融合基因。开始使用全身性皮质类固醇和低剂量伊马替尼治疗后,患儿症状消失。治疗9个月后,未再检测到FIP1L1-PDGFRA。

相似文献

1
Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis.一名非洲儿童的嗜酸性粒细胞增多症和严重骨病:一个意外的诊断。
BMJ Case Rep. 2019 Apr 29;12(4):e227653. doi: 10.1136/bcr-2018-227653.
2
Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript.因携带FIP1L1-PDGFRA转录本的嗜酸性粒细胞增多综合征而停用伊马替尼。
Leuk Lymphoma. 2016;57(3):708-10. doi: 10.3109/10428194.2015.1065983. Epub 2015 Oct 2.
3
Management of Hypereosinophilic Syndromes.高嗜酸性粒细胞综合征的管理
Immunol Allergy Clin North Am. 2015 Aug;35(3):561-75. doi: 10.1016/j.iac.2015.05.006.
4
Exquisite response to imatinib mesylate in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome: a 12-year experience of the Polish Hypereosinophilic Syndrome Study Group.FIP1L1-PDGFRA 突变的高嗜酸性粒细胞综合征对甲磺酸伊马替尼的卓越反应:波兰高嗜酸性粒细胞综合征研究组的 12 年经验
Pol Arch Intern Med. 2020 Mar 27;130(3):255-257. doi: 10.20452/pamw.15224. Epub 2020 Mar 3.
5
[Efficiency of imatinib in polyserositis revealing a FIP1L1-PDGFRA-negative hypereosinophilic syndrome].伊马替尼治疗多浆膜炎伴FIP1L1-PDGFRA阴性高嗜酸性粒细胞综合征的疗效
Rev Med Interne. 2010 Apr;31(4):305-8. doi: 10.1016/j.revmed.2009.08.005. Epub 2010 Feb 18.
6
[Synchronous detection of T-cell clonality and FIP1L1-PDGFRA fusion gene in a hypereosinophilic syndrome].[高嗜酸性粒细胞综合征中T细胞克隆性与FIP1L1-PDGFRA融合基因的同步检测]
Rev Med Interne. 2011 May;32(5):e66-8. doi: 10.1016/j.revmed.2010.06.003. Epub 2010 Jul 14.
7
Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome.甲磺酸伊马替尼的停药可能导致FIP1L1-PDGFRA突变的嗜酸性粒细胞增多综合征出现持续的血液学和分子学缓解。
Am J Hematol. 2014 Jan;89(1):115. doi: 10.1002/ajh.23588. Epub 2013 Oct 15.
8
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study.甲磺酸伊马替尼治疗FIP1L1-PDGFRα阳性高嗜酸性粒细胞综合征患者的疗效。一项多中心前瞻性研究的结果
Haematologica. 2007 Sep;92(9):1173-9. doi: 10.3324/haematol.11420. Epub 2007 Aug 1.
9
Imatinib for the treatment of hypereosinophilic syndromes.伊马替尼治疗高嗜酸性粒细胞综合征。
Expert Rev Clin Immunol. 2018 Feb;14(2):163-170. doi: 10.1080/1744666X.2018.1425142. Epub 2018 Jan 9.
10
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.低剂量甲磺酸伊马替尼可迅速诱导FIP1L1-PDGFRA阳性慢性嗜酸性粒细胞白血病出现主要分子反应并实现完全分子缓解。
Blood. 2007 Jun 1;109(11):4635-40. doi: 10.1182/blood-2006-10-050054. Epub 2007 Feb 13.

引用本文的文献

1
FIP1L1::PDGFRA Fusion in a Pediatric Patient Presenting With B-Cell Lymphoblastic Leukemia.一名患B细胞淋巴细胞白血病的儿科患者中发现FIP1L1::PDGFRA融合基因
Genes Chromosomes Cancer. 2025 Feb;64(2):e70037. doi: 10.1002/gcc.70037.
2
Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma.病例报告:伴有嗜酸性粒细胞增多和血小板衍生生长因子受体A(PDGFRA)重排的儿童髓系/淋系肿瘤:首例表现为B淋巴细胞母细胞淋巴瘤的病例
Front Pediatr. 2022 Dec 14;10:1059527. doi: 10.3389/fped.2022.1059527. eCollection 2022.
3
Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase -Associated Myeloid Neoplasm With Eosinophilia.伊马替尼单药治疗使一名伴有嗜酸性粒细胞增多的急变期相关髓系肿瘤儿童实现持续完全分子缓解。
Hemasphere. 2020 Nov 6;4(6):e486. doi: 10.1097/HS9.0000000000000486. eCollection 2020 Dec.

本文引用的文献

1
Hypereosinophilia in Children and Adults: A Retrospective Comparison.儿童和成人嗜酸性粒细胞增多症:回顾性比较。
J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):941-947.e1. doi: 10.1016/j.jaip.2016.03.020. Epub 2016 Apr 27.
2
Secondary Bone Marrow Fibrosis in Children And Young Adults: An Institutional Experience.儿童及青年继发性骨髓纤维化:一项机构经验
J Pediatr Hematol Oncol. 2016 Mar;38(2):97-101. doi: 10.1097/MPH.0000000000000452.
3
World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.世界卫生组织定义的嗜酸性粒细胞疾病:2015 年诊断、风险分层和管理更新。
Am J Hematol. 2015 Nov;90(11):1077-89. doi: 10.1002/ajh.24196.
4
Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.伊马替尼治疗血小板衍生生长因子受体A(PDGFRA)阴性的儿童嗜酸性粒细胞增多综合征
Pediatr Blood Cancer. 2016 Jan;63(1):164-7. doi: 10.1002/pbc.25702. Epub 2015 Aug 8.
5
The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases.FIP1L1-PDGFRA相关慢性嗜酸性粒细胞白血病的谱系:基于44例病例调查的新见解
Medicine (Baltimore). 2013 Sep;92(5):e1-e9. doi: 10.1097/MD.0b013e3182a71eba.
6
The laboratory diagnosis and follow up of strongyloidiasis: a systematic review.寄生虫性弱蚓病的实验室诊断和随访:系统评价。
PLoS Negl Trop Dis. 2013;7(1):e2002. doi: 10.1371/journal.pntd.0002002. Epub 2013 Jan 17.
7
FIP1L1-PDGFRα-positive hypereosinophilic syndrome in childhood: a case report and review of literature.儿童FIP1L1-PDGFRα阳性高嗜酸性粒细胞综合征:一例报告并文献复习
J Pediatr Hematol Oncol. 2014 Jan;36(1):e28-30. doi: 10.1097/MPH.0b013e31827e6386.
8
Hypereosinophilic syndrome in children.儿童嗜酸性粒细胞增多综合征。
Leuk Res. 2012 Oct;36(10):1249-54. doi: 10.1016/j.leukres.2012.05.025. Epub 2012 Jun 22.
9
Molecular characterization of paediatric idiopathic hypereosinophilia.小儿特发性嗜酸性粒细胞增多症的分子特征。
Br J Haematol. 2010 Dec;151(5):440-6. doi: 10.1111/j.1365-2141.2010.08394.x. Epub 2010 Oct 19.
10
Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.伴显著嗜酸性粒细胞增多和 PDGFRA 重排的髓系肿瘤,用甲磺酸伊马替尼治疗。
Pediatr Blood Cancer. 2010 Oct;55(4):730-2. doi: 10.1002/pbc.22655.